V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007532 | 250005271 | 1.76 | 72.6 | Palliative (P) | 2017-02-20 | 2017-02-25 | RUXOLITINIB | N | N | 250032297 | THALIDOMIDE |
| 250007533 | 250005272 | 0 | 110 | null | 2014-09-18 | 2014-09-18 | THALIDOMIDE | 02 | N | 250032302 | RITUXIMAB |
| 250007534 | 250005272 | 1.67 | null | null | 2017-12-13 | 2017-12-13 | RUXOLITINIB | 02 | N | 250032302 | ANAGRELIDE |
| 250007535 | 250005273 | 1.74 | 75.7 | Palliative (P) | 2014-09-27 | 2014-10-05 | PEMBROLIZUMAB | Y | N | 250032305 | ANAGRELIDE |
| 250007536 | 250005274 | null | 97.4 | Palliative (P) | 2013-06-27 | 2013-06-28 | Rituximab | 02 | N | 250032310 | RUXOLITINIB |
| 250007537 | 250005275 | 1.71 | 0 | Palliative (P) | 2016-02-28 | 2016-03-02 | RUXOLITINIB | N | N | 250032314 | RUXOLITINIB |
| 250007538 | 250005276 | 0 | 75.4 | Palliative (P) | 2015-10-22 | 2015-10-29 | RUXOLITINIB | 02 | N | 250032316 | BUSULPHAN |
| 250007539 | 250005277 | 1.87 | 0 | Palliative (P) | 2015-07-26 | 2015-07-27 | BUSULFAN | N | N | 250032318 | BUSULPHAN |
| 250007540 | 250005277 | 1.7 | null | Curative (C) | 2015-03-10 | 2015-03-12 | Pazopanib | 2 | null | 250032318 | ENZALUTAMIDE |
| 250007541 | 250005278 | null | 66.2 | null | 2017-10-20 | 2017-10-20 | RUXOLITINIB | N | N | 250032320 | INTERFERON |
| 250007542 | 250005278 | 1.52 | 88 | Palliative (P) | null | 2015-09-06 | RUXOLITINIB | N | N | 250032320 | CHOP R |
| 250007543 | 250005279 | 1.64 | null | Disease modification (D) | 2017-03-22 | 2017-03-22 | RUXOLITINIB | N | N | 250032324 | ABVD |
| 250007544 | 250005279 | 1.67 | 67.2 | Curative (C) | 2015-03-20 | 2015-03-21 | RUXOLITINIB | Y | N | 250032324 | RUXOLITINIB |
| 250007545 | 250005280 | null | null | Curative (C) | 2017-03-15 | 2017-03-15 | RUXOLITINIB | null | N | 250032330 | RITUXIMAB |
| 250007546 | 250005281 | null | null | Disease modification (D) | 2017-02-13 | 2017-02-13 | Pemetrexed | 1 | N | 250032333 | CISPLATIN + GEMCITABINE |
| 250007547 | 250009765 | 1.8 | 102 | Curative (C) | 2012-09-13 | 2012-09-15 | RUXOLITINIB | null | null | 250032339 | BUSULPHAN |
| 250007548 | 250005282 | 1.77 | 78.9 | Disease modification (D) | 2015-06-19 | 2015-07-27 | RUXOLITINIB | N | N | 250032343 | BUSULPHAN |
| 250007549 | 250009766 | null | null | Curative (C) | 2016-05-15 | 2016-05-15 | PEG INTERFERON | 1 | N | 250032345 | RITUXIMAB |
| 250007550 | 250005283 | 1.73 | 101 | Neo-adjuvant (N) | 2017-10-09 | 2017-10-09 | RUXOLITINIB | 02 | N | 250032346 | TRIAL |
| 250007551 | 250005284 | 1.56 | 69.6 | Palliative (P) | 2018-03-23 | 2018-03-23 | ABVD | N | N | 250032349 | RUXOLITINIB |
| 250007552 | 250005284 | 1.73 | null | Palliative (P) | null | 2016-02-02 | PEG INTERFERON | N | N | 250032349 | CHOP R |
| 250007553 | 250005284 | 0 | 89.2 | Palliative (P) | 2014-01-19 | 2014-01-19 | RUXOLITINIB | N | N | 250032349 | RITUXIMAB |
| 250007554 | 250005284 | 1.54 | 81 | Palliative (P) | 2018-01-02 | 2018-01-02 | Busulfan Oral | 2 | N | 250032349 | RUXOLITINIB |
| 250007555 | 250012711 | 1.72 | null | Curative (C) | 2016-03-26 | 2016-04-14 | FEC 100 + DOCETAXEL | 02 | N | 250032357 | INTERFERON |
| 250007556 | 250012711 | 1.44 | 92.4 | Palliative (P) | 2017-04-09 | 2017-04-09 | BENDAMUSTINE + RITUXIMAB | N | N | 250032357 | PEG INTERFERON |
| 250007557 | 250012711 | 1.64 | null | Disease modification (D) | 2014-11-25 | 2014-11-25 | Azacitidine | N | N | 250032357 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 250007558 | 250005285 | 1.77 | 60.5 | Curative (C) | 2016-09-20 | 2016-09-20 | Trial Unspecified | 2 | N | 250032364 | RUXOLITINIB |
| 250007559 | 250005286 | 1.7 | 82.4 | Disease modification (D) | 2017-09-27 | 2017-09-27 | Azacitidine | 1 | null | 250032365 | RUXOLITINIB |
| 250007560 | 250005287 | 1.58 | 81.3 | Disease modification (D) | null | 2015-05-19 | IMATINIB | N | null | 250032368 | TRIAL |
| 250007561 | 250009768 | 1.47 | null | null | null | 2016-05-26 | RUXOLITINIB | N | N | 250032372 | RITUXIMAB |
| 250007562 | 250009768 | 1.66 | null | null | 2016-05-01 | 2016-05-11 | Azacitidine | N | N | 250032372 | IMATINIB |
| 250007563 | 250005288 | 1.71 | null | Palliative (P) | 2017-09-21 | 2017-09-21 | RUXOLITINIB | N | N | 250032376 | ANAGRELIDE |
| 250007565 | 250009769 | 1.8 | 0 | Palliative (P) | 2017-01-05 | 2017-01-19 | RUXOLITINIB | N | N | 250032378 | RUXOLITINIB |
| 250007566 | 250009769 | 1.88 | null | Curative (C) | 2014-04-16 | 2014-04-16 | ANAGRELIDE | 02 | N | 250032378 | PEG INTERFERON |
| 250007567 | 250009769 | null | null | Adjuvant (A) | 2015-06-09 | 2015-06-09 | RUXOLITINIB | 01 | N | 250032378 | RUXOLITINIB |
| 250007568 | 250005290 | 1.75 | 0 | Palliative (P) | 2014-05-27 | 2014-05-27 | RUXOLITINIB | N | N | 250032389 | RUXOLITINIB |
| 250007569 | 250005290 | 0 | 86.3 | Disease modification (D) | 2014-02-12 | 2014-02-12 | Rituximab | N | N | 250032389 | RUXOLITINIB |
| 250007570 | 250005290 | 1.7 | null | Palliative (P) | 2017-12-05 | 2017-12-05 | RUXOLITINIB | 1 | N | 250032389 | ANAGRELIDE |
| 250007571 | 250012393 | null | 64 | Palliative (P) | 2013-08-29 | 2013-08-30 | RUXOLITINIB | N | N | 250032395 | PEG INTERFERON |
| 250007572 | 250005291 | 1.74 | 79 | Disease modification (D) | 2015-01-06 | 2015-01-06 | Rituximab | Y | N | 250032396 | TRIAL |
| 250007573 | 250005291 | 1.77 | 86.5 | Curative (C) | 2015-06-20 | 2015-06-21 | Rituximab | 02 | N | 250032396 | ANAGRELIDE |
| 250007574 | 250005291 | 1.55 | 0 | Disease modification (D) | 2013-11-11 | 2013-11-11 | RUXOLITINIB | Y | N | 250032396 | RUXOLITINIB |
| 250007575 | 250005292 | 1.79 | 63.8 | Disease modification (D) | 2017-07-12 | 2017-07-12 | ATG + Busulfan + Fludarabine | 2 | N | 250032404 | RITUXIMAB |
| 250007576 | 250005292 | 0 | 70.2 | Palliative (P) | 2015-10-06 | 2015-10-06 | Carboplatin + Vinorelbine IV | N | N | 250032404 | CVP R |
| 250007577 | 250011629 | 1.67 | 65.5 | Adjuvant (A) | 2017-05-08 | 2017-05-08 | RUXOLITINIB | 02 | N | 250032411 | AZACITIDINE |
| 250007578 | 250011629 | 1.62 | 74.4 | Disease modification (D) | 2014-11-25 | 2015-08-20 | RUXOLITINIB | N | N | 250032411 | AZACITIDINE |
| 250007579 | 250005293 | 0 | 73.9 | Palliative (P) | 2014-03-31 | 2014-04-03 | RUXOLITINIB | N | N | 250032419 | RUXOLITINIB |
| 250007580 | 250005294 | 0 | 79 | Palliative (P) | 2017-01-26 | 2017-01-26 | Cisplatin + Paclitaxel | N | N | 250032423 | DA |
| 250007581 | 250005294 | 0 | 84.6 | Palliative (P) | 2016-04-30 | 2016-04-30 | ANAGRELIDE | 02 | N | 250032423 | RITUXIMAB |
| 250007582 | 250005294 | 1.77 | null | null | 2013-06-25 | 2013-06-25 | RUXOLITINIB | N | N | 250032423 | BENDAMUSTINE + RITUXIMAB |